Chemed Gross Profit

The latest gross profit for CHE is $590M as of June 2026. That compares with $840M in the prior-year period — down 30.0% year over year. That is below the Healthcare sector average of $67B. Investors often review this figure alongside Chemed's historical trend and sector peers before judging valuation or financial health.

Over the past year, CHE's gross profit moved from $840M to $590M — a 30.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chemed's operating scale or balance-sheet position.

Against Healthcare companies, CHE currently prints $590M for gross profit, while the sector average sits near $67B. That is roughly 99.1% below the sector mean. Large gaps often invite a closer look at Chemed's growth, margins, and balance sheet.

A gross profit figure of $590M for CHE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $67B. Explore the charts below for those layers of context.

After noting CHE's gross profit ($590M), review year-over-year change from $840M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.